Early afternoon, after submitting a preliminary study of Gilead's vaccine in a China study to the WHO, it was "accidentally" posted in public to their web portal. The study showed that GILD's vaccine didn't really help. Supposedly this came out a few weeks ago, but it was discounted based on the study being terminated for poor enrollment. Didn't matter - when word got out, GILD spiked down and took along BCRX, based on similarity in the vaccine approach (although, supposedly not actual efficacy). BCRX got whallopped from 3.66 to 2.75 in short order, including a trading halt. Don't you hate that. Something huge happens and you can't find a reason, until a bit later from discussion threads. Always at a big disadvantage to the big guys with real-time, comprehensive news. After much humming and hawing, I opted to avg down a little with a purchase just under $3. Turned out well because the stock came mostly back with a close at $3.26. Yep, Monday was much better! lol
| 